Concepedia

Soazig Chevalier

SC

Statistics

Publications

4

Citations

405

H-Index

4

Active since

2008

Affiliations

Sanofi (France)(Current)

Institute of Oncology NN Petrov

University Hospital in Motol

KU Leuven

Masaryk Memorial Cancer Institute

Soazig Chevalier is an author at Sanofi (France) specializing in medicine, pharmacotherapy, and metastatic cancer management.

Publications per year

2008–2020

4

Publications

4

Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial

Josep Tabernero, Eric Van Cutsem, Radek Lakomý et al. · European Journal of Cancer · 2013 · 238 citations · Full text

, , +13

SERENADE: The Study Evaluating Rimonabant Efficacy in Drug-Naive Diabetic Patients

Julio Rosenstock, Priscilla Hollander, Soazig Chevalier et al. · Diabetes Care · 2008 · 123 citations · Full text

, , +17

Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy

Paul Ruff, David Ferry, Radek Lakomý et al. · European Journal of Cancer · 2014 · 24 citations · Full text

, , +17

Quality Tolerance Limits: Framework for Successful Implementation in Clinical Development

Ruma Bhagat, Łukasz Bojarski, Soazig Chevalier et al. · Therapeutic Innovation & Regulatory Science · 2020 · 20 citations · Full text

, , +8

1–4 of 4